Pioneering solutions for cardiovascular diseases and metabolic syndromes.
Our vision is to ease the significant burden of cardiovascular and metabolic diseases within Australia and beyond.
We’re working towards a deeper understanding, early detection and prevention of the collective major cause of death and disability in Australia: cardiovascular diseases and metabolic syndromes and diseases.
Heart disease, stroke, and the complications from diabetes and kidney disease affect all in our community—from children with congenital heart defects to myocardial infarction, stroke, diabetes, renal failure, heart failure and arrhythmias in the elderly.
The development of these disease patterns varies geographically, which means they are influenced beyond genetics by an intricate interplay of environmental, socio-demographic and behavioural factors.
The Heart Foundation will be launching a new grants management portal in the coming months.
UNSW researchers have recently identified novel biomaterials that incorporate molecules found in the extracellular matrix.
Professor Bruce Neal has been named among the world’s most influential researchers on Clarivate’s prestigious Highly Cited Researcher List for 2023.
The Cardiac, Vascular, and Metabolic Medicine Steering Committee is pleased to announce the recipients of the International Speaker Fellowship.